Search

Computer models suggest breast cancer screening guidelines for people with mutations in the genes ATM, CHEK2, and PALB2.

… Thursday, February 17, 2022 Many people have heard of mutations in the BRCA1 and BRCA2 genes that are linked to an increased risk of certain cancers, including breast cancer . But there are other, less well-known genes in which hereditary mutations can also increase breast cancer risk, including ATM

MSK chemists are focusing on developing small-molecule drugs to target KRas, an important cancer protein.

… Wednesday, May 24, 2017 Summary MSK chemists are focusing on developing small-molecule drugs to target KRas, an important cancer protein. KRas is linked to nearly 30% of all cancers. Drug development is a complicated task. In the era of targeted therapies for cancer, medicinal chemists seek to design

Dr. Mini Kamboj, MSK’s Chief Medical Epidemiologist, explains what people with cancer and their caregivers need to know about measles and the MMR (measles, mumps, and rubella) vaccine.

… Monday, February 9, 2026 More than 25 years ago, public health officials declared that measles had been eliminated in the United States. Today, however, due to declining vaccination rates, measles cases have surged to their highest levels in decades. Mini Kamboj, MD , MSK’s Chief Medical Epidemiologist

… Wednesday, March 10, 2010 Team GSK Raises Money for Rare Cancer Research Dimiter Tassev Team GSK Captain Dimiter Tassev On Feburary 6, teams of Gerstner Sloan Kettering students and faculty joined 2,500 indoor cyclists from New York and Chicago to raise more than $2.4 million to support rare cancer research

The drug, sotorasib, is targeted against a cancer-causing protein that has long been considered an “undruggable” target.

… Sunday, September 20, 2020 Summary In a study of people with lung cancer whose tumors contained the mutation targeted by sotorasib, 52 of 59 patients experienced disease control, which means that their tumors stopped growing. Update: On January 30, 2021, Memorial Sloan Kettering lung cancer expert Bob

A new tool developed by MSK scientists allows users to map metabolic data from kidney cancer tumors.

… Friday, February 5, 2016 Summary Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may

Awarded annually since 1955, the Sloan Research Fellowships honor exceptional U.S. and Canadian researchers whose creativity, leadership, innovation, and research accomplishments make them stand out as the next generation of leaders.

… Thursday, February 22, 2024 Memorial Sloan Kettering Cancer Center (MSK)  is proud to announce that  Yael David, PhD , chemical biologist leading The Yael David Lab and Associate Member of the Chemical Biology Program , has been selected as a 2024 Alfred P. Sloan Research Fellow in Chemistry. Dr. David

Learn what Zepbound, Wegovy, Ozempic and other weight loss drugs mean for cancer risk and treatment, from an expert at MSK.

… Tuesday, March 10, 2026 Ozempic, Zepbound, Wegovy, and related weight loss drugs have become some of the world’s most talked about medications in a remarkably short time. A growing body of research suggests these drugs may also be an important tool in reducing cancer related to obesity and higher levels

Discover how microbiome research is revealing the role that bacteria play in cancer treatment.

… Thursday, August 11, 2016 Summary Studies that analyze the microbiome — the community of organisms that live in the body — in cancer patients are revealing new findings about the connection between bacteria and health in cancer patients. Highlights One study has shown how microbes may trigger colitis

For men with inherited mutations in BRCA1 and BRCA2, a new program at MSK provides a “one-stop shop” for highly personalized cancer screening and surveillance.

… Thursday, June 16, 2022 Perhaps the best known of all the cancer predisposition genes are inherited mutations in the genes BRCA1 and BRCA2 . They were originally associated with an increased risk of breast and ovarian cancers . Later studies revealed they also raised the risk of prostate and pancreatic